Co-adjuvanting DDA/TDB liposomes with a TLR7 agonist allows for IgG2a/c class-switching in the absence of Th1 cells.
Zimmermann J, van Haren SD, Diray-Arce J, Adriawan IR, Wørzner K, Krog RT, Guleed S, Hu T, Mortensen R, Dietrich J, Solbak SMØ, Levy O, Christensen D, Pedersen GK.
Zimmermann J, et al. Among authors: adriawan ir.
NPJ Vaccines. 2023 Dec 22;8(1):189. doi: 10.1038/s41541-023-00781-0.
NPJ Vaccines. 2023.
PMID: 38135685
Free PMC article.